Eastman Kodak Company Common New trades as part of the technology sector and is part of the computer hardware industry. Eastman Kodak Co is a technology company providing imaging for business. It provides commercial products and services in technologies including materials science; digital imaging science and software; and deposition processes.
Previous Intraday Performance:
The KODK shares had a previous change of -1.67% which opened at 2.41 and closed at 2.35. It moved to an intraday high of 2.42 and a low of 2.34.
Over the last five trading days, KODK shares returned 3.07% and in the past 30 trading days it returned -4.47%. Over three months, it changed -33.62%. In one year it has changed -54.81% and within that year its 52 week high was 5.25 and its 52 week low was 2.20. KODK stock is 7.01% above its 52 week low.
Our calculations result in a 200 day moving average of 2.90 and a 50 day moving average of 2.49. Right now, KODK stock is trading -18.86% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $101.1m with 43.0m shares outstanding and a float of 37.9m shares. Trading volume was 101,429 shares and has experienced an average volume of 187,852 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Eastman Kodak Company Common New was -0.83 which ended on 31st of December 2018.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr 2019||Reported 05-09-2019:||-0.54|
|4th||Qtr 2018||Reported 11-09-2018:||-0.44|
|3rd||Qtr 2018||Reported 08-09-2018:||0.33|
|2nd||Qtr 2018||Reported 05-09-2018:||-0.02|
|1st||Qtr 2018||Reported 03-15-2018:||-0.70|
The long-term trend of the EPS is a vital number as it helps understand the future potential of Eastman Kodak Company Common New; the EPS growth rate, as it is usually called, is typically displayed as a percentage, which at this time is hard to estimate, but revenue growth has been -6.70% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 68.00% of institutional ownership. Short-interest was 5,718,888, which was 13.30% of shares outstanding. The short-interest ratio or days-to-cover ratio was 22.64. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.
The beta was calculated to be 2.34.
SeekingAlpha: Intra-Cellular Therapies beats by $0.24
Based on last reported financials, the company’s return on assets is -1.89%, profit margin is -0.77%, price-to-sales is 0.08 and price-to-book is 7.07.
Company Score Card:
Results are out of six:
2 : Growth Expectations Result
2 : Financial Safety Result
0 : Past Performance Result
0 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result